Beaumont Hospital, Dublin, Ireland
Beaumont Hospital, Dublin, Ireland.
BMJ Case Rep. 2021 Nov 2;14(11):e245898. doi: 10.1136/bcr-2021-245898.
MELAS, a mitochondrially inherited multisystem disorder, can present with acute stroke-like episodes. The literature thus far supports the use of L-arginine therapy in acute MELAS flares to alleviate and shorten the duration of symptoms. This is the case of a patient who presented with ataxia and worsening confusion on a background of genetically confirmed MELAS syndrome. In this instance, intravenous L-arginine therapy, along with corticosteroids, was administered in keeping with best practice. However, in a metabolically vulnerable patient, L-arginine therapy resulted in a further deterioration in his clinical status and the development of a non-anion gap metabolic acidosis.
MELAS 是一种线粒体遗传性多系统疾病,可表现为类似急性中风的发作。迄今为止,文献支持在急性 MELAS 发作时使用 L-精氨酸治疗以缓解和缩短症状持续时间。这是一位患者的病例,他在遗传性 MELAS 综合征的背景下出现共济失调和意识障碍恶化。在这种情况下,根据最佳实践,给予患者静脉内 L-精氨酸治疗和皮质类固醇治疗。然而,在代谢脆弱的患者中,L-精氨酸治疗导致其临床状况进一步恶化,并发展为非阴离子间隙代谢性酸中毒。